+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Patient Blood Management Market by Product Type, Therapy Type, Application, End User - Global Forecast to 2030- Product Image
Patient Blood Management Market by Product Type, Therapy Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Patient Blood Management Market by Product Type, Therapy Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5134244
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Patient Blood Management Market grew from USD 17.10 billion in 2024 to USD 18.50 billion in 2025. It is expected to continue growing at a CAGR of 8.03%, reaching USD 27.19 billion by 2030.

Redefining Patient Blood Management for the Modern Healthcare Era

Patient blood management has rapidly evolved into a cornerstone of modern healthcare, reflecting a shift from reactive transfusion protocols to proactive conservation practices. By integrating evidence-based strategies, clinicians can optimize patient outcomes while minimizing the risks and costs associated with allogeneic blood transfusions. This executive summary distills the essential trends, drivers, and strategic imperatives shaping the global landscape. It provides healthcare leaders, policymakers, and medical device innovators with a concise yet comprehensive overview of current dynamics and future directions.

In recent years, improvements in diagnostic techniques and technological advancements have transformed the way blood management is approached across surgical suites, trauma centers, and oncology wards. The emphasis on patient-centered care, cost containment, and regulatory compliance has elevated blood conservation from a clinical best practice to a strategic priority for healthcare systems worldwide. This introduction sets the stage for examining the transformative shifts, tariff impacts, segmentation insights, regional variations, competitive dynamics, and actionable recommendations that follow.

Emerging Innovations Driving a Paradigm Shift in Blood Care

The blood management landscape is undergoing transformative shifts driven by the convergence of technological breakthroughs and evolving clinical protocols. Point-of-care coagulation monitoring has gained traction as real-time analytics enable personalized transfusion strategies, reducing unnecessary blood utilization and associated complications. Simultaneously, advancements in autotransfusion systems and volume expanders are redefining intraoperative techniques, bolstering hemodynamic stability without reliance on donor products.

Parallel to technological innovation, therapy paradigms have expanded to encompass comprehensive perioperative optimization. Enhanced recovery pathways integrate pharmacological antifibrinolytics with meticulous cell salvage protocols, resulting in substantial reductions in postoperative transfusion rates. These converging trends underscore the move toward a closed-loop ecosystem in which diagnostics, devices, and pharmacotherapies coalesce to improve patient safety and operational efficiency.

Assessing the Effects of 2025 US Tariff Measures on Supply Chains

As of 2025, newly imposed tariffs by the United States on select medical devices and reagents have introduced complexity into global supply chains. Components integral to blood component separation systems and specialized disposables now face higher import duties, prompting manufacturers to reassess sourcing strategies and adjust pricing models. This shift has led to short-term cost pressures, particularly for hospitals and surgical centers reliant on offshore production hubs.

Manufacturers have responded by diversifying their supplier portfolios, exploring near-shoring opportunities, and investing in localized assembly lines to mitigate tariff exposure. While these adaptations require upfront capital, they are poised to enhance supply resilience and reduce lead times over the long term. Healthcare providers, in turn, are engaging more closely with vendors to negotiate volume-based agreements and secure stable pricing, ensuring uninterrupted access to critical blood management solutions.

Deep Dive into Market Segmentation Reveals Nuanced Growth Drivers

Insight into market segmentation reveals that product innovation and adoption vary significantly across technology categories. Antifibrinolytics continue to gain traction as clinicians prioritize pharmacological hemostasis, whereas autotransfusion systems are experiencing surging demand in cardiovascular and orthopedic surgeries. Blood management disposables such as cell washing kits, collection reservoirs, and filtration devices are critical for surgical teams aiming to maximize autologous blood retrieval and minimize waste. Laboratories and point-of-care settings benefit from advanced coagulation analyzers that provide rapid diagnostics, complementing labs where larger analyzers dominate routine testing workloads. Hemostats and sealants have diversified into sealant systems and topical agents, offering surgeons versatile tools to achieve hemostasis in challenging surgical fields.

Therapeutic approaches span from traditional allogeneic transfusion to sophisticated perioperative blood conservation methods. Antifibrinolytic therapy and topical hemostats are now integral to hemostasis management, while cell salvage and autologous transfusion provide patient-specific solutions that reduce donor dependency. Perioperative protocols increasingly incorporate preoperative optimization measures, such as iron supplementation, alongside intraoperative techniques and dedicated postoperative care pathways to preserve hemoglobin levels.

Applications range from cardiovascular surgery-including aortic procedures, bypass grafting, and valve replacements-to elective surgeries where blood conservation enhances recovery. Obstetric hemorrhage management and trauma care also harness closed-loop management systems to address acute bleeding. Oncology treatments, whether chemotherapy or radiotherapy, are leveraging supportive blood management technologies to mitigate anemia and improve patient quality of life.

End-user adoption of these innovations is most pronounced in acute care hospitals, which maintain the infrastructure to deploy complex devices and therapies. Ambulatory surgical centers emphasize minimally invasive disposables, and specialty centers such as trauma units, cancer treatment facilities, and cardiac care clinics prioritize integrated solutions that address their patient populations’ unique hemostatic challenges.

Regional Dynamics Shaping the Global Blood Management Landscape

The Americas region continues to lead in technology adoption and regulatory harmonization, driven by strong reimbursement frameworks and consolidated healthcare providers investing in blood management programs. North American hospitals are at the forefront of integrating point-of-care diagnostics with clinical decision support tools, while Latin American markets demonstrate growing demand for cost-effective disposables and generic pharmacotherapies.

Europe, the Middle East, and Africa present a diverse set of opportunities and challenges. Western European nations benefit from centralized procurement policies that promote standardized protocols and high-tech market entry, particularly in cardiovascular and oncological applications. In the Middle East, rising healthcare expenditures and government-backed initiatives fuel adoption of advanced hemostasis management, whereas Sub-Saharan Africa prioritizes scalable, low-cost solutions to address urgent transfusion needs in trauma and obstetric care.

Asia-Pacific markets are characterized by rapid hospital infrastructure expansion and increasing demand for minimally invasive procedures. With surgical volumes surging in Southeast Asia and quality care standards elevating across China and India, manufacturers are forging partnerships with local distributors to introduce autotransfusion systems and advanced sealant technologies. These collaborations help navigate regulatory complexities and adapt pricing models to diverse economic environments.

Profiling Industry Leaders and Strategic Collaborators in PBM

Leading players in the blood management arena are distinguished by robust product portfolios that span pharmacological agents, disposable systems, and diagnostic platforms. Strategic collaborations between device manufacturers and biotechnology firms are accelerating innovation in targeted hemostatic therapies and point-of-care monitoring tools. Companies with integrated R&D and global distribution networks are capitalizing on emerging markets by tailoring solutions to local clinical protocols and reimbursement landscapes.

Mergers and acquisitions continue to reshape the competitive terrain, with larger organizations acquiring niche innovators to bolster their offerings in autotransfusion and coagulation monitoring. Meanwhile, smaller firms focus on developing proprietary volume expanders and advanced sealant systems, securing patents that enhance their valuation. This dynamic interplay of consolidation and specialization is fostering a vibrant ecosystem in which collaborative research and licensing agreements drive next-generation blood management solutions.

Strategic Imperatives for Advancing Blood Management Excellence

Industry leaders should prioritize end-to-end integration of diagnostics, therapeutics, and disposables to deliver seamless blood management workflows. Investing in digital health platforms that aggregate perioperative data will empower care teams to make real-time decisions and demonstrate value through improved patient outcomes. Furthermore, forging partnerships with academic medical centers and key opinion leaders can accelerate clinical validation, paving the way for market differentiation.

To navigate tariff-related cost fluctuations, manufacturers and providers must adopt agile sourcing strategies and embrace near-shoring where feasible. Contractual arrangements tied to volume commitments can ensure stability in pricing and supply. Moreover, expanding training programs for surgical and nursing staff will be critical to maximizing the benefits of advanced devices and pharmacotherapies, driving adoption and reinforcing institutional support.

Rigorous Methodology Underpinning Our Market Insights

Our analysis is underpinned by a rigorous methodology combining primary interviews with clinical experts, hospital procurement professionals, and device innovators alongside secondary research from regulatory filings, peer-reviewed journals, and public financial disclosures. Each product segment, therapy type, application area, and end-user category was evaluated through qualitative and quantitative lenses to identify growth drivers, unmet needs, and competitive benchmarks.

Regional insights were derived from an appraisal of healthcare expenditure data, reimbursement policies, and infrastructural indices. Company profiles and competitive dynamics were assessed through a synthesis of press releases, patent filings, and transactional intelligence. This comprehensive approach ensures that our conclusions are grounded in real-world evidence and reflect the nuanced interplay of clinical, commercial, and regulatory factors shaping patient blood management.

Synthesis and Forward-Looking Perspectives on Blood Management

The evolution of patient blood management reflects a broader shift toward value-based care, where optimizing resource utilization aligns with superior clinical outcomes. By synthesizing the impacts of technological breakthroughs, tariff dynamics, segmentation nuances, regional disparities, and competitive strategies, this summary illuminates the multifaceted drivers transforming the field.

Looking ahead, continued collaboration among manufacturers, healthcare institutions, and policymakers will be essential to overcoming operational barriers and delivering patient-centric solutions. Embracing digital integration, supporting ongoing clinical research, and maintaining supply chain agility will ensure that blood management practices remain at the vanguard of surgical safety and therapeutic efficacy.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Antifibrinolytics
    • Autotransfusion Systems
    • Blood Component Separation Systems
    • Blood Management Disposables
      • Cell Washing Kits
      • Collection Reservoirs
      • Filtration Devices
    • Coagulation Monitoring Systems
      • Laboratory Analyzers
      • Point Of Care Devices
    • Hemostats And Sealants
      • Sealant Systems
      • Topical Hemostats
    • Volume Expanders
  • Therapy Type
    • Allogeneic Transfusion
    • Autologous Transfusion
    • Cell Salvage
    • Hemostasis Management
      • Antifibrinolytic Therapy
      • Topical Hemostats Therapy
    • Perioperative Blood Conservation
      • Intraoperative Techniques
      • Postoperative Care
      • Preoperative Optimization
  • Application
    • Cardiovascular Surgery
      • Aortic Surgery
      • Coronary Artery Bypass Grafting
      • Valve Replacement Procedures
    • Elective Surgery
    • Obstetrics
    • Oncology Treatments
      • Chemotherapy
      • Radiotherapy
    • Trauma
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
    • Specialty Centers
      • Cancer Treatment Centers
      • Cardiac Care Centers
      • Trauma Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Terumo Corporation
  • Baxter International Inc.
  • Roche Diagnostics International AG
  • Octapharma AG
  • CSL Limited
  • ZOLL Medical Corporation
  • Macopharma SA

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Patient Blood Management Market, by Product Type
8.1. Introduction
8.2. Antifibrinolytics
8.3. Autotransfusion Systems
8.4. Blood Component Separation Systems
8.5. Blood Management Disposables
8.5.1. Cell Washing Kits
8.5.2. Collection Reservoirs
8.5.3. Filtration Devices
8.6. Coagulation Monitoring Systems
8.6.1. Laboratory Analyzers
8.6.2. Point Of Care Devices
8.7. Hemostats And Sealants
8.7.1. Sealant Systems
8.7.2. Topical Hemostats
8.8. Volume Expanders
9. Patient Blood Management Market, by Therapy Type
9.1. Introduction
9.2. Allogeneic Transfusion
9.3. Autologous Transfusion
9.4. Cell Salvage
9.5. Hemostasis Management
9.5.1. Antifibrinolytic Therapy
9.5.2. Topical Hemostats Therapy
9.6. Perioperative Blood Conservation
9.6.1. Intraoperative Techniques
9.6.2. Postoperative Care
9.6.3. Preoperative Optimization
10. Patient Blood Management Market, by Application
10.1. Introduction
10.2. Cardiovascular Surgery
10.2.1. Aortic Surgery
10.2.2. Coronary Artery Bypass Grafting
10.2.3. Valve Replacement Procedures
10.3. Elective Surgery
10.4. Obstetrics
10.5. Oncology Treatments
10.5.1. Chemotherapy
10.5.2. Radiotherapy
10.6. Trauma
11. Patient Blood Management Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
11.5. Specialty Centers
11.5.1. Cancer Treatment Centers
11.5.2. Cardiac Care Centers
11.5.3. Trauma Centers
12. Americas Patient Blood Management Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Patient Blood Management Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Patient Blood Management Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Haemonetics Corporation
15.3.2. Fresenius Kabi AG
15.3.3. Grifols, S.A.
15.3.4. Terumo Corporation
15.3.5. Baxter International Inc.
15.3.6. Roche Diagnostics International AG
15.3.7. Octapharma AG
15.3.8. CSL Limited
15.3.9. ZOLL Medical Corporation
15.3.10. Macopharma SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PATIENT BLOOD MANAGEMENT MARKET MULTI-CURRENCY
FIGURE 2. PATIENT BLOOD MANAGEMENT MARKET MULTI-LANGUAGE
FIGURE 3. PATIENT BLOOD MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PATIENT BLOOD MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PATIENT BLOOD MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PATIENT BLOOD MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ANTIFIBRINOLYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AUTOTRANSFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD COMPONENT SEPARATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CELL WASHING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COLLECTION RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY FILTRATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY LABORATORY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY POINT OF CARE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SEALANT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY VOLUME EXPANDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ALLOGENEIC TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AUTOLOGOUS TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CELL SALVAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ANTIFIBRINOLYTIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TOPICAL HEMOSTATS THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INTRAOPERATIVE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY POSTOPERATIVE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AORTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY VALVE REPLACEMENT PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ELECTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY OBSTETRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TRAUMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TRAUMA CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 87. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 88. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 89. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 90. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 91. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 94. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 95. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 99. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 103. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 106. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 160. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 161. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 162. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 163. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 164. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 165. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 167. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 168. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 172. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 176. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 177. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 179. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 194. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 196. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 197. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 198. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 199. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 200. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 201. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 203. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 204. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 210. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 212. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 213. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 215. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 216. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 256. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 258. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 259. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 260. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 261. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 263. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 264. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 278. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 280. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 281. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 282. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 283. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 284. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 285. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 287. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 288. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 290. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 292. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 293. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2018-2030 (USD MILLION)
TABLE 294. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 295. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 296. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2018-2030 (USD MILLION)
TABLE 297. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 299. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2018-2030 (USD MILLION)
TABLE 300. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2018-2030 (USD MILLION)
TABLE 304. S

Companies Mentioned

The companies profiled in this Patient Blood Management market report include:
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Terumo Corporation
  • Baxter International Inc.
  • Roche Diagnostics International AG
  • Octapharma AG
  • CSL Limited
  • ZOLL Medical Corporation
  • Macopharma SA

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 18.5 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.19 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Patient Blood Management - Global Strategic Business Report - Product Image

Patient Blood Management - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Patient Blood Management Market Report 2025 - Product Image

Patient Blood Management Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Blood Transfusion Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030 - Product Image

Blood Transfusion Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Blood Screening Market by Test Type, Technology, End User, Sample Type, Testing Mode - Global Forecast to 2030 - Product Image

Blood Screening Market by Test Type, Technology, End User, Sample Type, Testing Mode - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Blood Typing Market Size, Share & Trends Analysis Report by Product & Services (Instruments, Reagents & Consumables), Test (Antibody Screening), Technique, End Use, Application, Region, with Growth Forecasts, 2025-2030 - Product Image

Blood Typing Market Size, Share & Trends Analysis Report by Product & Services (Instruments, Reagents & Consumables), Test (Antibody Screening), Technique, End Use, Application, Region, with Growth Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From

About the Patient Blood Management Market

Patient Blood Management (PBM) is a medical strategy that focuses on optimizing the care of patients who require blood transfusions. It is a multidisciplinary approach that involves the use of evidence-based practices to reduce the need for allogeneic blood transfusions, while ensuring the safety of the patient. PBM includes strategies such as preoperative anemia management, intraoperative blood salvage, and the use of alternative blood products. It also involves the use of blood conservation techniques such as cell salvage, erythropoietin, and iron supplementation. PBM is an important part of blood banking, as it helps to reduce the demand for allogeneic blood transfusions and improve patient outcomes. It is also beneficial to blood banks, as it helps to reduce the cost of blood products and improve the efficiency of the blood supply. Some companies in the PBM market include Fresenius Kabi, Haemonetics Corporation, Terumo BCT, and Grifols. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.